Back
Leap Therapeutics 10K Form
Sell
11
LPTX
Leap Therapeutics
Last Price:
$0.31
Seasonality Move:
-4.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LPTX News And Ratings
See the #1 stock for the next 7 days that we like better than LPTX
LPTX Financial Statistics
Sales & Book Value
| Annual Sales: | $1.5M |
|---|---|
| Cash Flow: | $-15.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.91 |
| Price / Book: | 0.37 |
Profitability
| EPS (TTM): | -1.84000 |
|---|---|
| Net Income (TTM): | $-67.6M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Leap Therapeutics Earnings Forecast
Key Leap Therapeutics Financial Ratios
-
Per Share Earnings over the last 13 years have been positive in 7 years.
Leap Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | LPTX |
| CUSIP: | 52187K |
| Website: | leaptx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LPTX Technical Analysis vs Fundamental Analysis
Sell
11
Leap Therapeutics (LPTX)
is a Sell
Is Leap Therapeutics a Buy or a Sell?
-
Leap Therapeutics stock is rated a SellThe current Leap Therapeutics [LPTX] share price is $0.32. The Score for LPTX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.